|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.000 USD | -2.60% |
|
-3.33% | +0.42% |
| 06-29 | Xilio Therapeutics, Inc.(NasdaqCM:XLO) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Xilio Therapeutics, Inc. Announces Appointment of Ben Harshbarger as Chief Legal Officer | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.60% | -3.33% | +7.91% | +4.77% | +0.42% | -13.08% | -75.74% | - | - | 55.28M | |
| -1.05% | +1.39% | +17.66% | +10.09% | +8.29% | +3.15% | +6.98% | -12.00% | +247.91% | 50.61B | |
| +0.96% | -2.18% | +16.40% | +26.73% | +133.91% | +385.56% | +598.84% | +522.28% | - | 39.11B | |
| +0.16% | +0.07% | +16.81% | +18.88% | -7.56% | +30.13% | -5.76% | -15.30% | +186.14% | 34.64B | |
| +1.15% | -0.40% | +14.73% | -0.74% | +1.29% | +22.04% | +56.73% | -7.59% | +947.01% | 33.79B | |
| -1.31% | -1.76% | -0.12% | -7.05% | +0.24% | +1.59% | +27.01% | -20.08% | +146.15% | 26.89B | |
| +0.74% | +0.13% | +19.71% | - | - | - | - | - | - | 16.47B | |
| +1.56% | -1.16% | +15.50% | +3.84% | -3.86% | +68.55% | +122.01% | +195.22% | - | 15.14B | |
| -0.72% | +0.12% | +8.87% | +0.76% | +10.58% | +14.69% | +16.95% | -32.46% | +106.19% | 13.85B | |
| +1.63% | +0.13% | +14.37% | +49.43% | -7.29% | +12.99% | -31.39% | -19.82% | +134.12% | 12.72B | |
| -1.17% | -6.39% | +39.48% | +12.30% | -1.41% | +1,528.26% | +637.27% | +303.06% | +2,830.86% | 11.8B | |
| +2.21% | +2.67% | +24.57% | +30.94% | +17.70% | +48.56% | +13.11% | -38.59% | +172.84% | 11.07B | |
| -0.23% | +0.82% | +26.74% | +21.36% | +21.05% | +35.29% | -15.47% | -35.99% | +154.52% | 11.12B | |
| +5.08% | -1.96% | +12.60% | +18.94% | -0.24% | +1.89% | - | - | - | 10.04B | |
| +0.21% | +0.41% | +55.57% | +51.56% | +77.64% | +244.87% | - | - | - | 10.03B | |
| +2.54% | -5.07% | +32.25% | +25.96% | +45.47% | +152.09% | +411.25% | +136.80% | - | 9.08B | |
| -3.00% | -36.19% | -25.51% | -28.23% | -30.36% | +29.47% | +29.68% | +56.24% | +124.67% | 9.38B | |
| +3.06% | +0.27% | +22.79% | -5.47% | +10.21% | +506.01% | +1,783.01% | +24.52% | - | 8.77B | |
| -1.81% | -7.95% | +14.59% | +50.07% | +81.67% | +71.20% | +66.98% | +112.15% | +6.83% | 8.65B | |
| +0.63% | +7.72% | +12.70% | -0.12% | -11.89% | -17.93% | -18.80% | -19.72% | +62.97% | 8.57B | |
| Average | +0.40% | -3.20% | +17.38% | +14.95% | +18.20% | +164.49% | +213.10% | +71.79% | +426.68% | 17.09B | |
| Weighted average by Cap. | +0.36% | -2.18% | +16.63% | +13.77% | +22.91% | +142.86% | +181.68% | +86.11% | +415.80% |
- Stock Market
- Stocks
- XLO Stock
- Sector Xilio Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
